Lv21
175 积分 2021-08-23 加入
First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial
1小时前
已完结
Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial
22天前
已完结
Combination of Radiotherapy and Immunotherapy in Advanced Non–Small Cell Lung Cancer
22天前
已完结
Outcomes and Treatments of Patients With Non–Small Cell Lung Cancer Who Received Pembrolizumab
22天前
已完结
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D Inhibitor
29天前
已完结
High-Dose Aumolertinib for Untreated EGFR-Variant Non–Small Cell Lung Cancer With Brain Metastases
29天前
已完结
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial
29天前
已完结
Long-Term Survival of Hypoimmune Allogeneic Islets without Immunosuppression
1个月前
已完结
ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection
4个月前
已完结
Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer
4个月前
已完结
皖公网安备34019202002308
